Spore-Cure 0.013 % Solution is a Health Canada–registered disinfectant drug (DIN 02557150) held by Veltek Associates Inc, containing Hypochlorous Acid. Health Canada lists its status as Marketed (status date 07 Jan 2026). Nexara Health has matched 4 registrations of Hypochlorous Acid across 2 other regulated markets.
Health Canada registration
| DIN | 02557150 |
|---|---|
| Brand name | Spore-Cure |
| Active ingredient | Hypochlorous Acid |
| Strength | 0.013 % |
| Dosage form | Solution |
| Route | DISINFECTANT (Hospital/HC Facilities) ; DISINFECTANT (Institutional/Industrial) |
| Company | Veltek Associates Inc |
| Status | Marketed — 07 Jan 2026 |
| Class | Disinfectant |
| ATC | V07AV TECHNICAL DISINFECTANTS |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Approved | Marketed |
| 2026-09-03 | Status | Approved | Marketed |
Hypochlorous Acid registered in other markets
4 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United Arab Emirates | Nexodyn Acidoxidizing Solution | Biokosmes srl, Italy, Bosisio Parini | Combination | Solution | Active | EDE |
| United Arab Emirates | Nexodyn Acidoxidizing Solution | Biokosmes srl, Italy, Bosisio Parini | Combination | Solution | Active | EDE |
| United Arab Emirates | Nexodyn Acidoxidizing Solution | Biokosmes srl, Italy, Bosisio Parini | Combination | Solution | Active | EDE |
| United States | RoyceDerm Stye Relief Eye Spray. | RoyceDerm LLC | Spray | listed | FDA NDC |
See every manufacturer of Hypochlorous Acid worldwide →
Related molecules (ATC V07AV)
- Alcohol Anhydrous
- Alcohol Denatured
- Alkyl Dimethyl Benzyl Ammonium Saccharinate
- Alkyl Dimethyl Ethylbenzyl Ammonium Chloride
- Benzalkonium Chloride
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Spore-Cure (DIN 02557150) marketed in Canada?
Yes. Health Canada lists DIN 02557150 as Marketed as of 07 Jan 2026.
Who holds the Canadian licence for this product?
Veltek Associates Inc is the company of record in the Health Canada Drug Product Database.
Is Hypochlorous Acid registered outside Canada?
Yes — Nexara Health has matched 4 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02557150, status date 2026-01-07; national medicine registries: EDE, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02557150, status date 2026-01-07; national medicine registries: EDE, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02557150, status date 2026-01-07; national medicine registries: EDE, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.